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ABSTRACT: As part of the program to develop contraceptive tools to control populations of over-abundant wildhfe species, the
NWRC has developed a single-injection gonadotropin-releasing hormone (GnRH) immunocontraceptive vaccine, GonaConm.
~ o n a ~ o n ~been
h a stested and shown to provide contraceptive effectslasting 1-3 years in many pest spzcies including white-tailed
deer, domestic and f e d pigs, bison, wild horses, cats, dogs, and California ground squirrels. GonaCon contains a GnRH peptide
conjugated to keyhole limpet hemocyanin c o m h i i with ~ d j u ~ a c 'an
" , adjuvant also developed at the USDA National Wildlife
Research Center. Immunization against GnRH prevents the circulating GnRH from stimulating the release of pituitary luteinizing
hormone and folliclestimulating hormone. This process of immunc-neutralization o_f GnRH effects a temporary non-surgical
castration in both males and females. Contraceptive and behavioral effectsof GonaCon are mscussed for a variety of species.
KEY WORDS:adjuvant, f d t y control, GnRH vaccine, Gonaconm,immunocontraception
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INTRODUCTION
A growing interest in nonlethal methods for
population control of nuisance or damaging species of
wildlife has fostered research in reducing f d t y of these
pest wildlife species. The most commonly used means of
inducing infertility is by immunocontraception, in which
the animal is immunized against a protein or hormone
needed for reproduction. Wildlife personnel have looked
at the values and shortcomings of immunocontraception
for several years and all have concluded that fuaher
research is wananted (Miller and Fagerstone 2000,
Fagerstone et al. 2002).
T d t i o n a l immunocontraceptive research in
mammals has concentrated on the use of a vaccine made
fYom zona pellucida extracted fYom the ovaries of pigs
(Sus scrofa) and therefore called porcine zona pellucida
(PZP) (Miller et al. 1999). Animals immunocontracepted
with PZP continue to cycle and are bred, but they do not
become pregnant due to the PZP antibody coating the
egg. In animals such as whitetailed deer (Odocoileus
virginianus) that continue to cycle throughout the
breeding season, the PZP contraceptive technique may
introduce physiological stress due to an extended
breeding season (K~llianand Miller 2000, Miller and
Killian 2000). This prolonged estrous cycling results in
increased activity during early winter, at a time when
conservation of calories is important. Increased activity
may also contribute to increased collisions with
automobiles in highly populated areas. Because of
concerns over prolonged estrous cycling, NWRC
developed a second contraceptive (GnRH vaccine) that
contracepts by reducing reproductive behavior.

DEVELOPMENT OF THE GnRHVACCINE
GnRH (gonadotropin-releasing hormone) is a small
peptide hormone sometimes called the "master hormone"
because it is responsible for controlling the reproductive
processes in both males and females. The GnRH peptide
is identical in all mammals and is not immunogenic both
because of its small size and because it is considered
"self' to the immune system. However, GnRH can be
made immunogenic by coupling it to a carrier such as
keyhole limpet hemocyanin (KLH). The coupled GnRH
peptide is called a GnRH conjugate, which then is
combined with an adjuvant to create a vaccine.
GnRH contraceptive vaccines have been evaluated as
immunocastration agents in pets, (cats, Felis sylvestris
catus; and dogs, Canis familiaris), cattle (Bos taum),
sheep (Ovis aries), swine, and deer (Odocoileus spp.)
(Adams and Adams 1992, Ladd et al. 1994, Meloen et al.
1994, Oonk et al. 1998, and Schanbacber 1982). All of
these GnRH studies have used 2 or more injections, and
the duration of the immune responses in many studies has
been 6 months or less. which is not vractical for wildlife
applications.
The fmt application of the NWRC GnRH vaccine
was a GnRHikeyhole limpet hemocyanin (KLH)I
Freund's combination, which was tested in the Noway
rat (Rattus norvegicus). In this study, which used a prime
and a boost vaccination (Miller et al. 1997). both male
and female rats remained &fertile for up to 1 Gear. The 2injection GnRH vaccine was then tested in white-tailed
deer. Details of this study were reported in Miller et al.
(2000). A commercial vaccine (Improvac) that required 2
injections was available for a short time in Australia,

but it was recently taken off the market (Dunshea et al.
2001).
~ k a u s eGnRH does not stimulate an immune
response by itself, the success of the vaccine depends on
the design of the conjugation. Each of the previous
authors mentioned above have their own GnRH
conjugation design. Ferro et al. (2002a, 2002b) have
studied several different designs of GnRH conjugation;
however, they still required multiple injections.
The design of a single-injection vaccine that will
provide multi-year contraceptive effect requires 1)
optimizing the vaccine structural design, 2) optimizing
the dose for each target species, 3) adding the best
adjuvant possible, and 4) designing a delivery system that
will protect the injected antigen from rapid destruction by
the immune system. The multi-injection vaccine is more
forgiving in relation to dose and the optimum vaccine
design. Details of the current GnRH vaccine developed
by NWRC are presented in a previous article (Miller et al.
2003). However, some general design concepts to
improve the vaccine effectiveness are presented here.

repetitive eptitope pattern influence the strength of the
primary response. He stresses that the greater the primary
response, the longer lasting the immune memory.
Bachmann et al. (1993) have shown that in obtaining a
high B cell responsiveness to an individual epitope, the
design of the immunogen is very important. They found
that high epitope density in a hlghly organized repetitive
fashion was important in B cell responsiveness. B cells
were unresponsive to poorly-organized but repetitive
epitopes. Repetitive epitopes of proper spacing are able
to stimulate multiple surface receptors of similar spacing.
Long-lasting immune response is thought to be due to a
combination of persisting antigen, which is capable of B
cell differentiation into plasma cells, and the persistence
of long-lasting plasma cells.
The bacterial mimic KLH-GnRH conjugate design,
combined with the new adjuvant (AdjuVac'"), which
contains small quantities of A4 avium, form the basis of
the new multi-year single-injection GnRH vaccine
GonaConT".

EFFECT OF GonaCour"TREATMENTIN
ADJUVANT DESIGN (AdjuVac'")
FEMALES
An important part of any vaccine is the adjuvant (a
Females are treated with GnRH vaccine by
non-specific immune stimulant). The most popular, and intramuscular injection. Effectiveness of the vaccme is
most controversial, adjuvant is Freund's Adjuvant, which tested by measuring the antibody levels to GnRH, and
has been widely used since 1945. This adjuvant has hormonal cyclic activity is measured by periodic
remained popular to immunologists over time because it sampling of serum concentrations of progesterone and
is so effective with all types of antigens. It is now known estradiol. Effective contraception in females reduces
that the addition of Mycobactenurn in Freund's complete hormone levels to the point that females do not ovulate or
adjuvant (FCA) provides a vital "danger signal" to the come into estms. In seasonal breeding animals such as
immune system that is the key to Freund's success. the white-tailed deer, a non-cyclic state is normal 6
Although many other adjuvants have been developed, months out of the year; GnRH-vaccinated females simply
none have matched the effectiveness of FCA. However, do not come into estrus in the fall. Field testing of the
because of the negative attitude of many animal care and GnRH vaccine includes monitoring the breeding activity,
use committees as well as Food and Drug Administration followed by monitoring the reduction of offspring in the
(FDA) concerns on the use of Freund's in any approved treated group as compared to the control group.
product, NWRC began testing a modified USDAGnRH vaccine has been tested in the female whiteapproved Johne's vaccine, Mycopai", as a replacement tailed deer for several years at both Pennsylvania State
for Freund's adjuvant. Mycopar is approved for use in University and Seneca Army Depot. We have found that
food animals and is therefore not a concern for use in GnRH reduces breeding behavior and reduces fawning
deer, which may be eaten by hunters.
for up to 4 years (Miller and Killian 2000).
The new adjuvant, which we have named AdjuVac'",
contains a small quantity of M. avium, a common bacteria EFFECTS OF GonaCod" TREATMENT IN MALES
found in many wildlife and domestic animals, which
Males are treated with GnRH vaccine by intramuscuprovides a similar "danger signal" to the immune system lar injection. Effectiveness of the vaccine is tested by
found in Freund's adjuvant. NWRC is currently testing measuring antibody levels to GnRH. Serum testosterone
AdjuVac'" in many different wildlife species and it concentrations are also measured. Testicular sue is
appears to be an effective replacement for Freund's as an measured, and sperm mobility and number are also
adjuvant for immunocontraception.
measured.
Effective contraception is the male is measured by the
drop in testosterone levels, reduction in the s u e of the
SINGLE-INJECTION GonaCod"MIMICS
BACTERIA
testicles, reduction in aggressive behavior, and the lack of
Many pathogens, including viruses and bacteria, interest in females that are in estrus.
exhibit a rigid, highly organized, highly repetitive pattem
The GnRH has been injected in the male white-tailed
of protein epitopes. This repetitive epitope pattern deer at Pennsylvania State University and at Seneca
provides a cross-linking activation of B cell receptors, Army Depot, where we found the annual growth of
resulting in an extremely strong, long-lasting immune antlers in male deer is dependant on testosterone, with
response (Bachmann et al. 1993). This mimic of the antler growth increasing with age and increased
repetitive nature of pathogen epitopes is an important part testosterone concentration. We have found large variaof the KLH-GnRH conjugate design. Banatvala et al. tion in the size of antlers in GnRH-treated male deer
(2001) state that the antigen dose and structure and (Curtis et al. 2001). Depending on the timing of the

veIy effective in reducing reproductive activity in the
female dog. The reproductive inhibition effect lasted 1
year in the male dog with a single injection; however, the
contraceptive effect should last longer in the female dog.
NWRC has begun a collaborative study with GnRH in
cats. The vaccine has reduced the testosterone and spem
counts in several male cats for up to 1 year with a single
injection (Levy et al. 2004). Dr. Julie Levy from the
University of Florida has received a Morris Foundation
Grant for a collaboration with NWRC to study the
reproductive effects of the GnRH in female cats.

vaccination, the antlers could fall off early, stay in velvet,
or have an abnormally small growth pattern.

DURATION OF CONTRACEPTIVE EFFECT
In animals treated with GnRH vaccine, anti-GnRH in
the hypophyseal portal blood complexes to the newly
released GnRH from the hypothalamus, preventing
GnRH from binding to the follicle-stimulating hormone
(FSH) and luteinizing hormone (LH) receptors. GnRH is
released from the hypothalamus in a pulse-related
fashion; the frequency and high of the pulse is related to
seasonal sexual activity or the phase of the estnrs cycle.
The concentration of new1 released GnRH in the portal Comparing Contraceptives in Wild Horses
In collaboration with Nevada State Veterinarian Dr.
blood is picogramid (10- gramsiml), and as it passes
into the peripheral blood its concentration drops to David Thaq researchers Dr. Jack Rhyan, Dr. Gary
femtogrami'd (lo-'' @ml).
This concentration is too Killian, and Dr. Lowell Miller are comparing the effects
small to measure even by the most sensitive of 3 contraceptive Techniques, SpayVac (a PZP formularadioimmunoassay method. GnRH-antibody complexes tion), GonaCon", and insertion of an IUD, in state-owned
produced in the portal blood are destroyed by the immune wild horses in Nevada. The fust year's data appear
system as they pass through the liver. Continued promising for all 3 techniques (K~llianet al. 2004a).
contraceptive effect is dependent on a continual source of
available GnRH antibody. This small quantity of GnRH GnRH Vaccine Reduces Disease
controls the concentration of the active reproductive GnRH Vaccine in Feral Pigs
Sexual transmission of pseudorabies in feral pigs has
hormones, progesterone and testosterone, which circulate
at nanogramslml (lo9 gramsid). It is this small quantity increased interest in the use of GnRH as a contraceptive,
of a master hormone that makes it a good candidate for which reduces fertility by reducing breeding activity. The
GnRH vaccine has been effective in reducing
immunocontraception.
In all the species tested, immunization with resulting reproduction in domestic pigs (Miller and Killian 2004a).
antibody titer to GnRH leads to an inhibition of breeding Feral swine are recognized as disease reservoirs for
behavior and contraception. Effective contraception brucellosis and psuedorabies, among other diseases, and
increase the risk of disease spread to other wildlife,
continues as long
- as antibody titers remain suficientlv they
domestic livestock and humans (Killian et al. 2004b).
high.
Effectiveness of the contraceptive response is dose Although the porcine zona pellucida vaccine has been
related. Our research has determined that the effective shown effeclive for contraception of several wildlife
dose can be divided into 3 general categories: small species pagerstone et al. 2002), its use in swine is
animal = 200 - 400 pg of conjugate, mid-sized animal = problematic because the vaccine is prepared using
800 - 1,000 gg of conjugate, and large-sized animal = porcine zona pellucida protein, which is a "self protein,"
1,500 - 2,000 l g of conjugate. Intra-muscular injections making it less immunogenic in the pig. Also, as previappear to be the most effective route of delivery. All ously mentioned, immunocontraception with the PZP
species show an apparent individual variation in immune vaccine may cause treated females to continue to cycle,
response to the vaccine. In species where there was increasing the opportunity to spread pseudorabies.
The GnRH vaccine may have an application in
initially 100% contraception, there was always a variation
between individuals in the length of the contraceptive making male pigs more palatable by reducing boar taint.
Dunshea et al. (2001) have shown that Improvac (a
response.
commercial GnRH vaccine) reduced boar taint in adult
male pigs. NWRC has unpublished studies that support
EFFECTS OF GnRH ON MAMMALS
these data both in domestic and feral pigs.
GnRH Vaccine in California Ground Squirrels
NWRC scientists in collaboration with staff from the
Alameda County, California, Vector Control District GnRH Vaccine in Bison
There are concerns over the spread of disease through
tested the use of a single-injection GnRH in the Califomia
ground squirrel (Spermophilus beecheyi). In the 2-year calving, such as brucellosis in bison. Bovine brucellosis,
study, 229 male and female squirrels were trapped and a bacterial disease is transmitted between animals
injected with a single-injection GnRH preparation. including cattle, bison (Bison bison), and elk (Ceryus
Results suggest a significant reduction in lactation in spp.), primarily through contact with infected aborted
females through the 2-year period, as well as a reduction fetuses, placentas, pamuient fluids, or post-parturient
uterine discharge. Following initial infection a dam often
in sexually-active males (Nash et al. 2004).
experiences abkion. ~ u b s c ~ u epregnanciks
nt
may result
in abortion or the birth of weak or normal calves and may
GnRH Vaccine in Feral Dogs and Cats
GnRH vaccine has shown to be effective in reducing also result in shedding of the organism. Contraception
the testosterone, sperm count, and sperm motility in a may therefore reduce the spread of the disease.
PZP is not an optimal contraceptive vaccine, because
small sample of test male dogs. The vaccine should be

Y-

1

prolonging the breeding season of bison in the Greater
Yellowstone Area may be deleterious to winter s u ~ v a l
of dominant bulls and vaccinated cows, due to increased
activity in fall and early winter. Immunocontraception
using GnRH vaccine has been shown to reduce
reproductive activity in the bison, and it is an alternative
to PZF' that would not extend the breeding season.
Female bison in a zoo setting have been given two GnRH
injections, which resulted in 100% reduction in calving
for over 2 years. Penned female bison in Idaho, when
given a single shot, have been contracepted for 1 year.
Four out of 5 bison were in the third trimester of
pregnancy at the time of GnRH vaccination and went on
to deliver normal calves. The following year, none of the
5 bison calved (Miller et al. 2004).

DISCUSSION
Imrnunowntraception through the use of GnRH
vaccine has intrigued reproductive physiologists for 20
years. The vaccine has been used to immunocastrate a
variety of animals with mixed success. Because of the
seasonal pulsating picogram quantity of GnRH, it
becomes the most logical hormone to bioneutralize, and
yet there is no GnRH vaccine on the market. Because
GnRH must be linked to a large protein to make it
immunogenic, the conjugate design has presented a
limiting factor in developing a successful long-acting
GnRH vaccine. The product development program of
NWRC has spent more than 10 years testing multiple
vaccine designs in white-tailed deer. As a result of these
studies, the current combination of the KLH-GnRH
conjugate design, T;ombined with a newlydeveloped
adjuvant AdjuVac , appears to provide an effeckve,
long-lasting vaccine, which we have named GonaCon .
GnRH vaccines have been criticized because of lack
of species specificity. Because GnRH has a similar
peptide sequence in all mammals, species specificity must
come with the injection delivery method. The positive
side of the lack of species specificity is that the same
vaccine can be used for multiple species with slight
variations in dosage.
GnRH has also been criticized because it reduces the
normal breeding behavior of the target animal. However,
seasonal breeders exhibit breeding behavior for 6 months
out of the year, so GnRH vaccine merely prolongs the
lack of sexual interest throughout the year. At this point
in time, there is no reproductive control method that does
not in some way interfere with reproductive behavior. As
GonaCon" becomes available as a contraceptive vaccine,
we should consider it a tool available for certain
situations, while we continue to research new and
improved control methods for future use.
The GnRH vaccine GonaConw has been shown to be
an effective sin~le-injection immunowntraceptive
vaccine. GonaCon is useful for many applications, one
of which is reducing breeding behavior of a particular
animal. Another application is to reduce aggression in
males. For example, male deer in parks become quite
used to people and can be fed in the non-breeding season;
however during the breeding season, these male deer can
become quite dangerous. A GnRH vaccination could
reduce this aggressive behavior. The vaccine can be used

as a single or multiple injections, and response is
generally reversible in 1 to 4 ~ e a r sdepending
,
on the dose
given. The GnRWAdjuVac vaccine, called GonaCon",
has an APHIS USDA patent-pending status.
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